Top News

• FDA Remaking Inspection Priorities in Wake of Trump Cuts
• Can FDA Do More With Less?: McClellan
• FDA Misses Novavax Covid Vaccine Review Action
• Industry Sounds the Alarm on FDA Staff Cuts
• Positive EDG-7500 Heart Drug Phase 2 Results
• Biogen Gets Fast Track for Alzheimers Therapy
• Ocrevus IV Phase 3 Study Misses Primary Endpoint
• RFK Jr. Invited to Senate Hearing on HHS Reorganization